SCHEMBL16405459

SCHEMBL16405459

CC(C)(C)Cc1cc(C(C)(C)C)ccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.62
ALDH1A1 P00352 2/20 0.57
HPGD P15428 1/20 0.57
ALOX15 P16050 1/20 0.57
HSD17B10 Q99714 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
KLF10 Q13118 1/20 0.53
MAPT P10636 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
GAA P10253 1/20 0.52
PKM P14618 1/20 0.52
RECQL P46063 1/20 0.52
CYP1A2 P05177 1/20 0.51
CYP2C19 P33261 1/20 0.51
ESR1 P03372 5/20 0.48
ESR2 Q92731 3/20 0.48
TSHR P16473 1/20 0.47
CYP3A4 P08684 2/20 0.45
HIF1A Q16665 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16405458 0.84 ALDH1A1 (0.57) CYP2D6ALDH1A1HPGDALOX15HSD17B10
SCHEMBL51058 0.83 CYP2D6 (0.67) CYP2D6ALDH1A1HPGDALOX15HSD17B10
SCHEMBL21002165 0.83 CYP2D6 (0.67) CYP2D6ALDH1A1HPGDALOX15HSD17B10
SCHEMBL1229448 0.82 ESR1 (0.71) CYP2D6ALDH1A1HPGDALOX15HSD17B10
SCHEMBL5636034 0.82 KLF10 (0.78) CYP2D6ALDH1A1HPGDALOX15HSD17B10
SCHEMBL30124085 0.82 KLF10 (0.78) CYP2D6ALDH1A1HPGDALOX15HSD17B10
SCHEMBL9290335 0.80 CYP2D6 (0.62) CYP2D6ALDH1A1HPGDALOX15HSD17B10
SCHEMBL28591107 0.80 CYP2D6 (0.62) CYP2D6ALDH1A1HPGDALOX15HSD17B10
SCHEMBL10026837 0.79 ESR1 (0.50) CYP2D6ALDH1A1HPGDALOX15HSD17B10
SCHEMBL10874465 0.78 CYP2C19 (0.67) CYP2D6ALDH1A1HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108698389-B Multilayer film and method of manufacture 日本瑞翁株式会社 2020-04-28 CN disclosed
US-9795549-B2 1,2-alkane polyol-containing composition OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) 2017-10-24 US disclosed
US-20170209441-A1 AMINOQUINOLINE DERIVATIVES AND USES THEREOF UNIVERSITY OF DELHI (IN) 2017-07-27 US disclosed
US-9567316-B2 Aminoquinoline derivatives and uses thereof THE MCLEAN HOSPITAL CORPORATION (US) 2017-02-14 US disclosed
US-20160045414-A1 1,2-ALKANE POLYOL-CONTAINING COMPOSITION OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) 2016-02-18 US disclosed
EP-2985017-A1 1,2-ALKANE POLYOL-CONTAINING COMPOSITION Osaka Organic Chemical Ind., Ltd. (JP) 2016-02-17 EP disclosed
US-20150023930-A1 AMINOQUINOLINE DERIVATIVES AND USES THEREOF THE MCLEAN HOSPITAL CORPORATION (US) 2015-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150023930-A1 AMINOQUINOLINE DERIVATIVES AND USES THEREOF LRRK2, NLN, AADAT CYP2D6 1830/4885ALDH1A1 2094/4885HPGD 879/4885
US-20170209441-A1 AMINOQUINOLINE DERIVATIVES AND USES THEREOF LRRK2, NLRP3, AADAT CYP2D6 1351/4885ALDH1A1 1990/4885HPGD 1667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.